- Report
- October 2024
- 194 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- January 2025
- 200 Pages
Global
From €2279EUR$2,490USD£1,937GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- May 2025
- 194 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1373EUR$1,500USD£1,167GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1144EUR$1,250USD£972GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Report
- April 2025
- 112 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- January 2025
- 173 Pages
Global
From €4572EUR$4,995USD£3,886GBP
- Report
- January 2025
- 210 Pages
Global
From €4572EUR$4,995USD£3,886GBP
- Report
- April 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- December 2024
- 119 Pages
Global
From €3616EUR$3,950USD£3,073GBP
- Report
- October 2024
- 186 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- October 2024
- 182 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- August 2024
- 142 Pages
Global
From €2745EUR$2,999USD£2,333GBP
- Report
- January 2025
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- June 2024
- 132 Pages
North America
From €3662EUR$4,000USD£3,112GBP
- Report
- August 2023
- 85 Pages
United States
From €4440EUR$4,850USD£3,773GBP

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs.
The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more